UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study

Neuro-oncology (Charlottesville, Va.), 2015-06, Vol.17 (6), p.854-861

2015

Volltextzugriff (PDF)

Efficacy and safety of CDX-301, recombinant human Flt3L, at expanding dendritic cells and hematopoietic stem cells in healthy human volunteers

Bone marrow transplantation (Basingstoke), 2015-07, Vol.50 (7), p.924-930

2015

Volltextzugriff (PDF)

Dendritic cell-targeted protein vaccines: a novel approach to induce T-cell immunity

Journal of internal medicine, 2012-02, Vol.271 (2), p.183-192

2012

Volltextzugriff (PDF)

A prime/boost vaccine platform efficiently identifies CD27 agonism and depletion of myeloid-derived suppressor cells as therapies that rationally combine with checkpoint blockade in ovarian cancer

Cancer Immunology, Immunotherapy, 2021-12, Vol.70 (12), p.3451-3460

2021

Volltextzugriff (PDF)

Determinants of response to T‐cell stimulation by CD27 antibody therapy in lymphoma: The RiVa trial

Hematological oncology, 2023-06, Vol.41 (S2), p.281-283

2023

Volltextzugriff (PDF)

Antibody-targeted vaccines

Oncogene, 2007-05, Vol.26 (25), p.3758-3767

2007

Volltextzugriff (PDF)

CD27 STIMULATION ENHANCES CD20 MAB THERAPY THROUGH ACTIVATION OF INNATE IMMUNITY

Hematological oncology, 2017-06, Vol.35 (S2), p.134-135

2017

Volltextzugriff (PDF)

Antigen delivery to early endosomes eliminates the superiority of human blood BDCA3+ dendritic cells at cross presentation

The Journal of experimental medicine, 2013-05, Vol.210 (5), p.1049-1063

2013

Volltextzugriff (PDF)

Internalization and endosomal degradation of receptor-bound antigens regulate the efficiency of cross presentation by human dendritic cells

Blood, 2012-09, Vol.120 (10), p.2011-2020

2012

Volltextzugriff (PDF)

In vivo targeting of HIV gag to dendritic cells in combination with poly ICLC is safe and immunogenic in healthy volunteers

Retrovirology, 2012-09, Vol.9 (S2), p.O51-O51, Article O51

2012

Volltextzugriff (PDF)

Autoimmunity in a Phase I Trial of a Fully Human Anti-Cytotoxic T-Lymphocyte Antigen-4 Monoclonal Antibody With Multiple Melanoma Peptides and Montanide ISA 51 for Patients With Resected Stages III and IV Melanoma

Journal of clinical oncology, 2005-02, Vol.23 (4), p.741-750

2005

Volltextzugriff (PDF)

953P - Safety and efficacy of CDX-014, an antibody-drug conjugate against T Cell immunoglobulin mucin-1 (TIM-1), in advanced renal cell carcinoma

Annals of oncology, 2019-10, Vol.30, p.v384-v385

2019

Volltextzugriff (PDF)

Safety and efficacy of CDX-014, an antibody-drug conjugate against T Cell immunoglobulin mucin-1 (TIM-1), in advanced renal cell carcinoma

Annals of oncology, 2019-10, Vol.30, p.v384-v385

2019

Volltextzugriff (PDF)

Targeting Weak Antigens to CD64 Elicits Potent Humoral Responses in Human CD64 Transgenic Mice

The Journal of immunology (1950), 2000-12, Vol.165 (12), p.6738-6742

2000

Volltextzugriff (PDF)

953PSafety and efficacy of CDX-014, an antibody-drug conjugate against T Cell immunoglobulin mucin-1 (TIM-1), in advanced renal cell carcinoma

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

D100 CDX-0159, AN ANTI-KIT MONOCLONAL ANTIBODY, AS A MODULATOR OF MAST CELL-RELATED DISEASES

Annals of allergy, asthma, & immunology, 2019-11, Vol.123 (5), p.S14-S14

2019

Volltextzugriff (PDF)

Mannose receptor-targeted vaccines

Expert opinion on biological therapy, 2004-12, Vol.4 (12), p.1953-1962

2004

Volltextzugriff (PDF)

Receptor modulation by Fc gamma RI-specific fusion proteins is dependent on receptor number and modified by IgG

The Journal of immunology (1950), 2001-12, Vol.167 (11), p.6303-6311

2001

Volltextzugriff (PDF)

Anti-HPA-1a-mediated platelet phagocytosis by monocytes in vitro and its inhibition by Fc gamma receptor (FcγR) reactive reagents

European journal of haematology, 2003-02, Vol.70 (2), p.67-74

2003

Volltextzugriff (PDF)

430 Intradermal injection of antigen: Antibody fusion proteins directed against lectin receptors targets defined dendritic cell subsets in human skin and elicits T cell responses

Journal of investigative dermatology, 2016-09, Vol.136 (9), p.S234-S234

2016

Volltextzugriff (PDF)

Specific Growth Stimulation by Linoleic Acid in Hepatoma Cell Lines Transfected with the Target Protein of a Liver Carcinogen

Proceedings of the National Academy of Sciences - PNAS, 1992-06, Vol.89 (11), p.4830-4834

1992

Volltextzugriff (PDF)

Activity and Safety of CTLA-4 Blockade Combined with Vaccines in Cynomolgus Macaques

The Journal of immunology (1950), 2003-12, Vol.171 (11), p.6251-6259

2003

Volltextzugriff (PDF)

Humanized mAb H22 binds the human high affinity Fc receptor for IgG (FcgammaRI), blocks phagocytosis, and modulates receptor expression

Journal of leukocyte biology, 1997-10, Vol.62 (4), p.469-479

1997

Volltextzugriff (PDF)

The human anti-CD30 antibody 5F11 shows in vitro and in vivo activity against malignant lymphoma

Blood, 2003-11, Vol.102 (10), p.3737-3742

2003

Volltextzugriff (PDF)

Mannose Receptor Targeting of Tumor Antigen pmel17 to Human Dendritic Cells Directs Anti-Melanoma T Cell Responses via Multiple HLA Molecules

The Journal of immunology (1950), 2004-03, Vol.172 (5), p.2845-2852

2004

Volltextzugriff (PDF)

1 – 25 von 595

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(424)
Mit Volltextzugriff
(401)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

6 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 30 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study

Efficacy and safety of CDX-301, recombinant human Flt3L, at expanding dendritic cells and hematopoietic stem cells in healthy human volunteers

Dendritic cell-targeted protein vaccines: a novel approach to induce T-cell immunity

A prime/boost vaccine platform efficiently identifies CD27 agonism and depletion of myeloid-derived suppressor cells as therapies that rationally combine with checkpoint blockade in ovarian cancer

Determinants of response to T‐cell stimulation by CD27 antibody therapy in lymphoma: The RiVa trial

Antibody-targeted vaccines

CD27 STIMULATION ENHANCES CD20 MAB THERAPY THROUGH ACTIVATION OF INNATE IMMUNITY

Antigen delivery to early endosomes eliminates the superiority of human blood BDCA3+ dendritic cells at cross presentation

Internalization and endosomal degradation of receptor-bound antigens regulate the efficiency of cross presentation by human dendritic cells

In vivo targeting of HIV gag to dendritic cells in combination with poly ICLC is safe and immunogenic in healthy volunteers

Autoimmunity in a Phase I Trial of a Fully Human Anti-Cytotoxic T-Lymphocyte Antigen-4 Monoclonal Antibody With Multiple Melanoma Peptides and Montanide ISA 51 for Patients With Resected Stages III and IV Melanoma

953P - Safety and efficacy of CDX-014, an antibody-drug conjugate against T Cell immunoglobulin mucin-1 (TIM-1), in advanced renal cell carcinoma

Safety and efficacy of CDX-014, an antibody-drug conjugate against T Cell immunoglobulin mucin-1 (TIM-1), in advanced renal cell carcinoma

Targeting Weak Antigens to CD64 Elicits Potent Humoral Responses in Human CD64 Transgenic Mice

953PSafety and efficacy of CDX-014, an antibody-drug conjugate against T Cell immunoglobulin mucin-1 (TIM-1), in advanced renal cell carcinoma

D100 CDX-0159, AN ANTI-KIT MONOCLONAL ANTIBODY, AS A MODULATOR OF MAST CELL-RELATED DISEASES

Mannose receptor-targeted vaccines

Receptor modulation by Fc gamma RI-specific fusion proteins is dependent on receptor number and modified by IgG

Anti-HPA-1a-mediated platelet phagocytosis by monocytes in vitro and its inhibition by Fc gamma receptor (FcγR) reactive reagents

430 Intradermal injection of antigen: Antibody fusion proteins directed against lectin receptors targets defined dendritic cell subsets in human skin and elicits T cell responses

Specific Growth Stimulation by Linoleic Acid in Hepatoma Cell Lines Transfected with the Target Protein of a Liver Carcinogen

Activity and Safety of CTLA-4 Blockade Combined with Vaccines in Cynomolgus Macaques

Humanized mAb H22 binds the human high affinity Fc receptor for IgG (FcgammaRI), blocks phagocytosis, and modulates receptor expression

The human anti-CD30 antibody 5F11 shows in vitro and in vivo activity against malignant lymphoma

Mannose Receptor Targeting of Tumor Antigen pmel17 to Human Dendritic Cells Directs Anti-Melanoma T Cell Responses via Multiple HLA Molecules

Suchergebnisse filtern